Author(s): Donepudi Pradyumna, Lankalapalli Srinivas, Nallamothu Krishna

Email(s): pradyu1986@gmail.com

DOI: 10.52711/0974-360X.2024.00279   

Address: Donepudi Pradyumna*, Lankalapalli Srinivas, Nallamothu Krishna
GITAM School of Pharmacy, GITAM (Deemed to be) University, Visakhapatnam, India.
*Corresponding Author

Published In:   Volume - 17,      Issue - 4,     Year - 2024


ABSTRACT:
Budesonide, a corticosteroid, was used as a model drug to study the effects of independent variables like HPMC K4M as a release retarding polymer at 2-6% and Crospovidone as a super disintegrant at 2-5% on in vitro drug release to meet desired Q points of dissolution. Current study used a 32 factorial design (Stat-Ease Design Expert v12) to formulate a mini-tablet in an enteric-coated capsule to treat ulcerative colitis utilising ECDDT and mini-tablets. An in vivo study was conducted in New Zealand rabbits to determine the pharmacokinetic parameters for the optimized formulation (BF4-O). Time vs. plasma concentration plots of the Pure drug and Optimized formulation was observed. Plotted Area under the curve indicates the extent of drug absorption inside the body. Pharmacokinetic analysis of Budesonide pre drug plasma concentration–time data provided the following pharmacokinetic parameters like Cmax value ranging (1.42 ± 2.12 ng/mL), Tmax value (4.0 Hours), AUC value (12.77 ± 0.15 h.ng/mL), Half Life (3.5 Hours) and other pharmacokinetic parameters are depicted. Study demonstrates the variability in pharmacokinetic parameters like Tmax, Cmax, T1/2 (Hours), AUC and Ke. Henceforth, the newly developed Mini-Tablet in Enteric Coated capsule could be utilized clinically for the treatment of Ulcerative Colitis, alternatively with cost-effectiveness.


Cite this article:
Donepudi Pradyumna, Lankalapalli Srinivas, Nallamothu Krishna. In-vivo study of Budesonide mini-tablets in enteric coated capsules for the treatment of ulcerative colitis. Research Journal of Pharmacy and Technology.2024; 17(4):1758-2. doi: 10.52711/0974-360X.2024.00279

Cite(Electronic):
Donepudi Pradyumna, Lankalapalli Srinivas, Nallamothu Krishna. In-vivo study of Budesonide mini-tablets in enteric coated capsules for the treatment of ulcerative colitis. Research Journal of Pharmacy and Technology.2024; 17(4):1758-2. doi: 10.52711/0974-360X.2024.00279   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-4-53


REFERENCES:
1.    Pawar VK, Meher JG, Singh Y, Chaurasia M, Reddy BS, Chourasia MK. Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives. Int J Pharm. 2014; 196: 168-183.
2.    Sai Sheela A, Mathrusri Annapurna M and Spandana Yasaswini R. New validated stability indicating RP-UFLC method for the determination of Budesonide. Research Journal of Pharmacy and Technology, 2020; 13(6): 2819-2824.
3.    Sai Pavan Kumar Bandaru and Mathrusri Annapurna M. Development and validation of a new stability indicating RP-HPLC method for the quantification of Budesonide in pharmaceutical dosage forms in presence of an internal standard. Research Journal of Pharmacy and Technology. 2022; 15 (5): 2103-2109.
4.    Choonara BF, Choonara YE, Kumar P, Bijukumar D, du Toit LC, Pillay VA. Review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. Biotechnology Advances. 2014; 32: 1269-1282.
5.    Raymond C. Rowe., Paul J Sheskey., Marian E Quinn. Handbook of pharmaceutical excipients; 6th edition. 2009.
6.    Donepudi Pradyumna, Lankapalli Srinivas. Formulation and evaluation of Budesonide mini-tablet in enteric coated capsule for the treatment of ulcerative colitis using a factorial design approach. Eur. Chem. Bull. 2023; 12 (Special Issue 5): 6311-6321.
7.    OECD Guideline for Testing of Chemicals: Acute Dermal Irritation, Corrosion, revised version, Guideline No. 404, adopted May 1981.OECD, Rome, Italy.
8.    Guide for care and use of laboratory animals: Public Health Service: National Institutes of Health NIH Publication No. 86-23 Revised 1985.
9.    Teresa Gazzotti, Andrea Barbarossa, Elisa Zironi, Paola Roncada, Marco Pietra, Giampiero Pagliuca: An LC–MS/MS method for the determination of Budesonide and 16a-hydroxyprednisolone in dog plasma, Methods X. 2016; 3: 139-143.
10.    Collins BA, Dima MA Ivosev G, Zhong F. A high dynamic range pulse counting detection system for mass spectrometry. Rapid Comm Mass Spect 2013; 28(2): 209-216.
11.    Yamani NS and Mathrusri Annapurna M. New stability indicating RP-HPLC method for the estimation of budesonide in API and pharmaceutical dosage forms. Asian Journal of Pharmaceutics. 2021; 15 (4): 498-503.
12.    USFDA: Guidance for Industry: Bioavailability and bioequivalence studies for orally administered drug products-General considerations. US Department of Health and Human Services: Food and Drug Administration: Centre for Drug Evaluation and Research (CDER), Rockville, MD 2003.


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available